Introduction
Wheat (Triticum aestivum) is a main component of the daily diet but can cause three distinct forms of wheat allergy: Baker's asthma, wheat food allergy and wheat pollen allergy. The panel of wheat allergens is still incomplete. The aim of the study was to identify and characterize wheat allergens for the development of improved diagnostic tests and allergen-specific forms of treatment.
Methods
A cDNA library was screened with serum from wheat food allergic patients. The cDNAs coding for allergens were subjected to sequence comparison, cloned into E. coli expression vectors and recombinant allergens were purified. The IgE reactivity of the recombinant allergens was tested by non-denaturing RAST-based dot blot analysis with sera from clinically well defined patients suffering from wheat food allergy or Baker's Asthma.
Results
We isolated a cDNA coding for the C-terminal part of a low molecular weight glutenin which has not yet been described as an allergen. The C-terminal part as well as the full length protein were expressed as soluble proteins in E. coli and purified. More than 80% of wheat food allergic children (n=26) showed IgE reactivity with the complete recombinant glutenin whereas only 5% of Baker's Asthma patients (n=60) showed specific IgE reactivity.
Conclusion
We identified a low molecular weight as a novel major wheat food allergen which can be used for the development of component-resolved diagnostic tests for wheat food allergy and eventually for specific immunotherapy.
